Furthermore, our meta-analysis examined only one polymorphism, whereas analysis of multiple genetic polymorphisms in the same gene might provide a more complete picture of the role of XRCC3 in mediating glioma risk. The gene discussed is XRCC3; the disease is central nervous system cancer.